An Introduction to Account-Based Marketing in B2B Life Sciences

3.5.2026
[time] min read

The B2B life sciences sector operates under a highly specific set of commercial constraints. Organizations selling complex technical products, clinical services, or capital equipment to pharmaceutical, biotech, and academic institutions face a challenging landscape. It is an environment defined by buying committees composed of people with highly specific yet varied needs, long sales cycles, and a risk-averse customer base.

In this context, traditional volume-based marketing—casting a wide net to capture generic "leads"—is less effective than a targeted marketing framework. Account-Based Marketing (ABM) provides this foundational architecture, aligning perfectly with how high-value, complex purchasing decisions are actually made in the life sciences.

Critical Definition: Account-Based Marketing (ABM) is a structurally significant go-to-market strategy that aligns the entire commercial revenue engine—marketing, sales development (SDR), and business development (BD)—around a targeted set of high-value accounts. Rather than marketing to an industry, marketers target accounts and buying groups that are most likely to engage and buy a specific solution offering.

The Realities of Life Science Commercialization

To understand why ABM is seeing widespread adoption among life science organizations, one must analyze the realities of the industry's sales process. High-value B2B life science sales are rarely transactional. They are characterized by three distinct factors:

  1. Extended Sales Cycles: Taking a product from preclinical research through Phase I-III clinical trials and eventual commercialization is a multi-year endeavor. Consequently, the buying cycles for the tools and services that support this process are exceptionally long.
  2. Complex Buying Groups: A single scientist rarely possesses unilateral purchasing authority for a $500k capital equipment purchase or a $2M contract research organization (CRO) engagement. Decisions are made by consensus among a buying committee that may include Principal Investigators, VPs of Clinical Operations, Regulatory Affairs Directors, and Procurement Officers.
  3. Inherent Risk Aversion: Purchasing the wrong technology or partnering with the wrong service provider can delay clinical pipelines, risk regulatory censure, or jeopardize research. Therefore, life science buyers are skeptical and require robust, observable evidence before initiating a change in their standard operating procedures.

Disconnected, overly promotional marketing tactics fail to address these realities. A broad email blast cannot alleviate the specific regulatory concerns of a Director of Quality Assurance, nor can a generic webinar speak to the exact therapeutic area challenges of a Translational Scientist.

The Core Principles of Life Science ABM

ABM addresses these industry hurdles by replacing disjointed campaigns with targeted Commercial Orchestration. A mature ABM framework in the life sciences is built upon several foundational pillars:

  • Precision Targeting via the ICP: Rather than targeting "biotech companies," ABM requires a highly defined Ideal Customer Profile (ICP). Marketers identify accounts based on exact parameters: therapeutic areas in development, specific clinical trial phases, funding rounds, and product modalities (e.g., cell and gene therapy versus small molecule).
  • Persona-Level Mapping: Once a high-value account is identified, the strategy shifts to mapping the buying group. Marketing creates distinct, evidence-based content streams tailored to the unique operational pain points of each persona within that specific account.
  • Complete Commercial Alignment: In a traditional model, marketing generates a lead and hands it "over the wall" to sales. In ABM, marketing, SDRs, and BD professionals operate in lockstep. Outreach is coordinated so that when marketing delivers an account-specific white paper, the SDR follows up with contextual relevance, creating a seamless experience for the buyer.

Traditional Demand Generation vs. Commercial Orchestration

To fully grasp the transformative nature of ABM, it is helpful to contrast it with the traditional demand generation models that many life science companies still employ.

Strategic Element Traditional Demand Gen Account-Based Marketing
Primary Focus Volume of individual leads across a broad market segment. Engagement of entire buying committees within specific target accounts.
Messaging Strategy Feature-led, generic, and broadly applicable. Evidence-based, contextual, and tailored to the account's clinical phase.
Commercial Alignment Siloed. Marketing generates leads; sales attempts to qualify them. Integrated. Marketing and BD collaboratively define targets and orchestrate outreach.
Key Performance Indicator Marketing Qualified Leads (MQLs) and Cost Per Lead (CPL). Pipeline velocity, Sales Qualified Accounts (SQAs), Deal size, and Return on Marketing Investment.

By aligning the entire commercial team on strategy and targeted outreach, ABM enables organizations to connect authentically at every stage of the buyer's journey. It replaces the noise of generic promotion with the authority of an evidence-based advisor. The result is a more efficient revenue engine, shortened sales cycles, and improved commercial success in securing high-value, long-term partnerships.

Fractorial provides ABM services specifically designed for the realities of how B2B life science companies can best identify, target, and communicate to their ideal targets. Learn more at fractorial.digital/abm.

More articles

An Introduction to Account-Based Marketing in B2B Life Sciences

3.5.2026
[time] min read

The B2B life sciences sector operates under a highly specific set of commercial constraints. Organizations selling complex technical products, clinical services, or capital equipment to pharmaceutical, biotech, and academic institutions face a challenging landscape. It is an environment defined by buying committees composed of people with highly specific yet varied needs, long sales cycles, and a risk-averse customer base.

In this context, traditional volume-based marketing—casting a wide net to capture generic "leads"—is less effective than a targeted marketing framework. Account-Based Marketing (ABM) provides this foundational architecture, aligning perfectly with how high-value, complex purchasing decisions are actually made in the life sciences.

Critical Definition: Account-Based Marketing (ABM) is a structurally significant go-to-market strategy that aligns the entire commercial revenue engine—marketing, sales development (SDR), and business development (BD)—around a targeted set of high-value accounts. Rather than marketing to an industry, marketers target accounts and buying groups that are most likely to engage and buy a specific solution offering.

The Realities of Life Science Commercialization

To understand why ABM is seeing widespread adoption among life science organizations, one must analyze the realities of the industry's sales process. High-value B2B life science sales are rarely transactional. They are characterized by three distinct factors:

  1. Extended Sales Cycles: Taking a product from preclinical research through Phase I-III clinical trials and eventual commercialization is a multi-year endeavor. Consequently, the buying cycles for the tools and services that support this process are exceptionally long.
  2. Complex Buying Groups: A single scientist rarely possesses unilateral purchasing authority for a $500k capital equipment purchase or a $2M contract research organization (CRO) engagement. Decisions are made by consensus among a buying committee that may include Principal Investigators, VPs of Clinical Operations, Regulatory Affairs Directors, and Procurement Officers.
  3. Inherent Risk Aversion: Purchasing the wrong technology or partnering with the wrong service provider can delay clinical pipelines, risk regulatory censure, or jeopardize research. Therefore, life science buyers are skeptical and require robust, observable evidence before initiating a change in their standard operating procedures.

Disconnected, overly promotional marketing tactics fail to address these realities. A broad email blast cannot alleviate the specific regulatory concerns of a Director of Quality Assurance, nor can a generic webinar speak to the exact therapeutic area challenges of a Translational Scientist.

The Core Principles of Life Science ABM

ABM addresses these industry hurdles by replacing disjointed campaigns with targeted Commercial Orchestration. A mature ABM framework in the life sciences is built upon several foundational pillars:

  • Precision Targeting via the ICP: Rather than targeting "biotech companies," ABM requires a highly defined Ideal Customer Profile (ICP). Marketers identify accounts based on exact parameters: therapeutic areas in development, specific clinical trial phases, funding rounds, and product modalities (e.g., cell and gene therapy versus small molecule).
  • Persona-Level Mapping: Once a high-value account is identified, the strategy shifts to mapping the buying group. Marketing creates distinct, evidence-based content streams tailored to the unique operational pain points of each persona within that specific account.
  • Complete Commercial Alignment: In a traditional model, marketing generates a lead and hands it "over the wall" to sales. In ABM, marketing, SDRs, and BD professionals operate in lockstep. Outreach is coordinated so that when marketing delivers an account-specific white paper, the SDR follows up with contextual relevance, creating a seamless experience for the buyer.

Traditional Demand Generation vs. Commercial Orchestration

To fully grasp the transformative nature of ABM, it is helpful to contrast it with the traditional demand generation models that many life science companies still employ.

Strategic Element Traditional Demand Gen Account-Based Marketing
Primary Focus Volume of individual leads across a broad market segment. Engagement of entire buying committees within specific target accounts.
Messaging Strategy Feature-led, generic, and broadly applicable. Evidence-based, contextual, and tailored to the account's clinical phase.
Commercial Alignment Siloed. Marketing generates leads; sales attempts to qualify them. Integrated. Marketing and BD collaboratively define targets and orchestrate outreach.
Key Performance Indicator Marketing Qualified Leads (MQLs) and Cost Per Lead (CPL). Pipeline velocity, Sales Qualified Accounts (SQAs), Deal size, and Return on Marketing Investment.

By aligning the entire commercial team on strategy and targeted outreach, ABM enables organizations to connect authentically at every stage of the buyer's journey. It replaces the noise of generic promotion with the authority of an evidence-based advisor. The result is a more efficient revenue engine, shortened sales cycles, and improved commercial success in securing high-value, long-term partnerships.

Fractorial provides ABM services specifically designed for the realities of how B2B life science companies can best identify, target, and communicate to their ideal targets. Learn more at fractorial.digital/abm.

Read article

SEO vs. SEM vs. AEO vs. GEO: Navigating the New Architecture of Digital Discovery

1.27.2026
[time] min read

In the current digital marketing landscape, the ground is shifting beneath our feet. For over two decades, the relationship between content creators and search engines was governed by what we call the "Traditional Bargain": marketers created high-quality, freely accessible content, and in exchange, search engines like Google directed relevant traffic to their websites. However, the rise of AI-driven discovery—specifically Answer Engines and Generative Engines—is fundamentally altering this agreement. For leadership in technical sectors like the life sciences, understanding both traditional search as well as AI-driven search is essential for deploying digital resources to ensure your authority remains visible.

A Short History of Search: From Curated Links to the Academic Model

To understand our current state, it’s helpful to know a bit about the history of search. Early web search was a digital Wild West. Starting with directory-style listings like AltaVista to early search engines like Yahoo, the process was often inefficient and ineffective. It was common for a user to click on a dozen or more links in order to find just one that was useful—if they ever found one at all. Furthermore, results could be manipulated through techniques like "keyword stuffing," which led to irrelevant results and a poor user experience.

Google revolutionized this landscape by adopting a logic borrowed from academia and scientific literature: ranking the relevance and importance of a page based on the number and quality of "citations" (links) pointing to it—much like how the significance of a peer-reviewed article is inferred. This revolutionary approach meant that results were based not just on what the engine saw on a page, but on what other real users and creators thought of that content.

This birthed the era of digital content marketing. Web creators realized that by developing high-quality, useful content, they could improve their site's authority and climb the rankings. Google actively encouraged this because their business model relied on providing the most relevant results to keep users coming back.

The Traditional Bargain was simple:

For Marketers: Invest time in creating great, free content, and Google will reward you with traffic that you can then convert into customers.

For Google: Encourage a web of great content to provide the best results for users, allowing Google to run highly relevant ads alongside those results to generate revenue.

But as AI usage becomes increasingly common, this bargain is changing. Users can now get answers in entirely new ways, which impacts how marketers must approach discovery.

Let’s explore the current (early 2026) status of search: from organic (unpaid) search, to paid search, to answer engines, and generative engines.

Search Engine Optimization (SEO): The Organic Foundation

Organic search is the foundation of search - unpaid results when a user searches for something. SEO is the art and science of getting your website to rank high in organic search results. It relies on a combination of high-quality content, technical site health, and established authority through backlinks.

Imagine you are in Denver, Colorado, and you are dealing with a blocked toilet. You go to Google and search for "plumber near me".

  • The Result: Google may list businesses, and will also provide a list of organic links. Some might be actual plumbers, while others might be directory sites like Yelp. We can also see what is essentially a message board (Reddit) ranking, as Google thinks the discussion on the board may be useful.
  • The Experience: While these results are relevant, you have to click on each link, evaluate the company’s service area, read through their pages, and find their contact information manually. It requires significant effort from the user to filter through the options to find an ideal match.
  • The Strategy: SEO is still the bedrock of building a digital presence and building digital authority and (free) traffic. What you do to rank well in organic search can improve your ranking in paid search and in AI-powered search.

Search Engine Marketing (SEM): Targeted Paid Results

SEM is the paid side of search. Companies pay for their site to appear at the very top of the results page for specific, high-intent keywords, often through platforms like Google Ads.

Using the same "plumber near me" search in Denver:

  • The Result: At the very top, you see multiple "Sponsored" results.
  • The Experience: These results may be more immediately useful than organic ones. They frequently include star ratings, direct "Call" buttons, and a link to book an appointment.
  • The Strategy: Google makes an effort to make paid results useful because they generate revenue when these links are clicked. For the marketer, it provides instant visibility at the exact moment a customer has a need. However, without rigorous CRM integration and attribution tracking, SEM can become an inefficient spend. For life science organizations, SEM must be compliant and carefully managed to reach technical personas with precision.

Answer Engine Optimization (AEO): The Zero-Click Reality

AEO is a newer modality where the user no longer receives a list of links. Instead, they are provided with a direct result synthesized by a Large Language Model (LLM) or "Answer Engine". This is most commonly seen in Google's AI Overviews (AIO) or platforms like Perplexity. (Keep in mind terms like AEO and GEO are not fully settled, and the definitions may still change.)

Instead of a keyword search, the user might type a statement like: "I have a blocked toilet."

  • The Result: Google’s AI Overview pulls content from multiple web sources to form a single, cohesive answer right on the search page.
  • The Experience: The user might get all the immediate troubleshooting steps they need without ever clicking a link. While the sources are cited on the side, the traffic often stays within Google, and no click occurs (zero-click). This is where the Traditional Bargain breaks. The engine effectively repurposes your content but keeps the traffic for itself.
  • The Nuance: While losing traffic is a risk, some argue that "no-click" users might have been low-quality targets anyway. High intent users may be looking for the content cited to find companies with authority, and may be more likely to then engage with your site and your company.

Generative Engine Optimization (GEO): Influencing AI Recommendations

GEO focuses on ensuring your company is presented and recommended by generative engines—such as ChatGPT, Gemini, or Claude—when a user asks for a recommendation or a complex comparison.

A user might ask Google’s Gemini: "What plumbers near me do you recommend?"

  • The Result: The engine provides a synthesized response that might include a comparison of highly-rated local favorites, details on their specialties, and even advice on what to do before they arrive.
  • The Experience: This is a personalized and useful response. A user is very likely to consider the plumbers specifically recommended by the AI before looking at a traditional list of links.
  • The Strategic Value: Showing up in these generative responses is incredibly valuable because the AI acts as a trusted advisor, endorsing your business to the user. Consider a life science example: when a C-suite executive asks an AI, "Which CRO has the best track record for Phase II clinical trials in rare diseases?", GEO ensures your organization is the one recommended. It is about ensuring your "digital footprint" is authoritative enough for models to synthesize your value proposition accurately.
  • The Strategic Reality: There is no "GEO strategy" separate from brand building. AI models are trained on the same content that builds your brand everywhere else. To win at GEO in life science marketing, you need mentions in authoritative publications, case studies that genuinely help people, and a strong reputation in your niche.

Should You Care About AEO and GEO?

The transition to AI-powered search raises a critical question: should you significantly change your strategy?

The Case for Caring About GEO: Users who ask generative engines for recommendations are often deep in the consideration phase. Being the recommended solution is a powerful competitive advantage. Building your brand will naturally build GEO and is something you should already be doing. 

The Case for Caution With AEO: If AEO satisfies the user's curiosity immediately, your click-through rates may drop. Putting effort into ranking highly for answer engines (especially at the expense of improving SEO) may not be the best strategy for your business. You do have the chance to develop authority by being shown, and some users may click through, but many may not. (However, many of these "no-click" users may not have really been good targets.)

How to Optimize for the Future

Transitioning to this new era requires moving from "managing a website" to "managing a technical narrative" parsed by both humans and machines. Regardless of whether you focus strongly on AEO and GEO, there are ways to position your company well.

  1. Structure for Machines: Use schema markup and structured data to help answer engines and LLMs easily parse and cite your expertise.
  2. Build High-Value Content: Focus on "high-value" assets like proprietary research, technical white papers, webinars, and case studies. These are the signals that generative engines use to verify your authority. Additionally, AI models are trained on the web's collective knowledge. The more your brand is mentioned in authoritative contexts, the more likely you are to be a GEO recommendation.
  3. Audit Your Data: Ensure you have a unified data ecosystem. You need to see if those "zero-click" AI interactions are actually leading to downstream revenue. This will help you determine whether you should alter your focus for the future.

Aside from focusing on search, continue to develop engagement and authority through other means. Use a mix of email, social, and direct engagement to own your audience so that you aren't entirely dependent on the changing "search bargain".

Conclusion: Strategies for the New Era

Despite these shifts, the core of successful B2B marketing remains the same: building authority. Especially in the life sciences, where buyers are inherently skeptical and sales cycles are long, your technical authority is your most valuable asset. By building scientifically fluent content and a robust data foundation, you ensure that no matter how search changes, your business remains the primary signal in an increasingly noisy, AI-driven world.

References & Further Reading

If you're looking to dive deeper into the technical nuances and industry debates surrounding these emerging search technologies, here are some additional resources:

  • WTF are GEO and AEO? (and how they differ from SEO)Digiday
  • Why We Should Stop Saying Generative Engine Optimization — Answer Engine Optimization Makes More SenseForbes
  • Déjà Vu All Over Again? Answer Engine Optimization Is a Familiar TrapContent Marketing Institute
  • AEO vs. GEO: Why they're the same thing (and why we prefer AEO)Profound
Read article

How to Gain Lead Flow Insights with a Sankey Diagram

12.2.2025
[time] min read

The Importance of Data Visualization in Marketing

In modern marketing we generate significant amounts of commercial data, yet especially in life sciences marketing we often suffer from insight scarcity. The role of a marketing leader is not just to generate leads, but align with the commercial organization, understand how marketing is working, and engineer a consistent revenue engine. To do this, effectively visualizing your data in order to create actionable insights is critical.

Just as a scientist visualizes experimental results to make hypotheses and plan next steps, a marketing leader must visualize the "Commercial Physiology" of their organization. Effective visualization can help diagnose friction points, calibrate budget allocation, and validate the return on investment for complex, multi-channel strategies.

Standard vs. Complex Charts and Diagrams

Most marketing dashboards rely on a standard set of static visuals: bar charts for volume, line graphs for trends, and basic funnel diagrams for conversion rates and movement from one stage of engagement to the next. While these are useful for isolating specific metrics (e.g., "How many MQLs did we generate last month?"), they fail to capture the fluidity and interconnectivity of a more complex marketing organization - especially where multiple touchpoints or sales team layers exist. A linear funnel assumes a single path to purchase, but the reality of life science procurement is non-linear and complex. To map this reality and provide deeper insights into commercial lead and opportunity flow, a Sankey diagram can be highly useful.

What is a Sankey Diagram and Why is it Useful for Marketers?

a generic Sankey diagram

A Sankey diagram is a specific type of flow diagram where the width of the arrows is proportional to the flow quantity. For marketers, it's a highly useful tool for visualizing how leads move through your entire commercial system.

Unlike a basic funnel, a Sankey diagram provides a high-fidelity view of:

  • Volume Source: Exactly how many leads are coming from each specific channel (e.g., Webinars vs. paid search vs. ABM) and where those leads enter the funnel.
  • Systemic Movement: How those leads traverse—or fail to traverse—the commercial stages.
  • Data Hygiene Gaps: Perhaps most importantly, the process of constructing a Sankey diagram acts as a stress test for your data. If you try, but can't construct a Sankey that connects a lead source all the way to a closed-won deal, you've now identified gaps in your tracking infrastructure and you will struggle to report on ROI from your marketing efforts.

How to Create a Marketing Sankey

Creating a Sankey diagram is as much a process of "Data Harmonization" as it is design.

  • Step 1 - Select Your Tool: Identify the tools you will use. There are many dedicated Sankey web sites likes sankeyart.com or SankeyMATIC.com, and there are even Excel plugins to allow you to create a Sankey directly from your Excel data. We prefer SankeyMATIC for its combination of ease of use, flexibility, and price (free!)
  • Step 2 - Data Gathering: You must list out every lead source and define your funnel stages (i.e. MQL, SQL, SAL, Opportunity, etc.) Consistency in naming conventions is critical here to ensure the data flows logically.
  • Step 3 - Define How Leads Flow: Not all leads behave the same. Some leads flow from one stage to the next, some leads may move directly to BD. Some leads may enter the funnel as MQLs; some may enter and immediately be triaged as SQLs. You must map the logic: do "hot" leads go directly to Sales? Do "warm" leads go to Nurture? This triage logic must be explicitly defined in your data set.
  • Step 4 - "Dummy Data" As Needed: If your current CRM data is messy, or if you can’t perfectly map out all of these steps, keep going! It is a highly valuable exercise to create "dummy data" to map out what your ideal process should look like. This allows you to visualize the "Theoretical Funnel" and identify exactly where your real-world data is failing to match the model, and can help you figure out how to build in systems to allow you to better fully track your leads and funnel.

Case Study: Creating a Sankey for a Multi-Channel Life Science Engine

For an example of how to create a Sankey, let’s look at a hypothetical case study of a mid-sized life science organization:

Commercial Structure

The organization consists of three distinct commercial units: a Marketing Team generating inbound interest and nurturing leads, a Sales Development (SDR) team performing outreach to generate warm leads, and also turning marketing leads into meetings, and a Business Development (BD) team closing deals while also sourcing some of their own deals.

Data Inputs

We will utilize the following data set to construct our "Commercial Flow." Note how we track multiple distinct channels for lead generation:

Top of Funnel (MQL Sources):

  • Conferences (2000)
  • Webinars (1000)
  • Account-Based Marketing (2500)
  • Gated Content (400)

Mid-Funnel (Qualification):

  • The SDR team sources 1000 leads directly.
  • MQLs are triaged: 1000 move to SQL status, while the remainder are automatically routed to a Nurture phase.

Bottom Funnel (Conversion):

  • SQLs convert to Meetings/SAL (Sales Accepted Leads). Those that do not convert return to Nurture.
  • We also track "Direct-to-Meeting" sources, including high-intent SEO traffic (200), Paid Search (100), and leads sourced directly by the BD team (50).

Revenue Realization: We track the flow from Meetings (200) to Opportunities and finally to 75 Won Business deals.

Input Code

Based on the data inputs above, we can create a code block showing lead sources and destinations in the format of 'Source [number of leads] Destination Stage'. Here is the code based on the data inputs above:

// Top of Funnel Inputs
Conferences [2000] MQL
Webinars [1000] MQL
ABM [2500] MQL
Gated Content [400] MQL

// Mid-Funnel Triage
SDR Team [1000] SQL
MQL [1000] SQL
MQL [*] Nurture  // Remainder of MQLs move to Nurture
Nurture [150] Meetings/SAL // Nurture re-engagement

// Sales Handoff
SQL [150] Meetings/SAL
SQL [*] Nurture // Unconverted SQLs return to Nurture
SEO [200] Meetings/SAL
Paid Search [100] Meetings/SAL
BD Team [50] Meetings/SAL

// Revenue
Meetings/SAL [200] Opportunity
Opportunity [75] Won Business

Output

Here is the output Sankey diagram, created in SankeyMATIC.com:

A Sankey diagram in orange, scarlet, and teal showing leads flows and stages from lead to won business

Interpreting the Sankey Diagram

Now that we have created our Sankey using the code above, we can analyze and see what it shows us. By visualizing our lead flows and stages, we can immediately see the importance of the nurture stage, and of continuous nurturing to drive meetings. We can observe that while ABM drives the highest volume of MQLs, a significant portion require nurturing before becoming sales-ready. Conversely, we can validate that SDR-sourced leads have a more direct path to SQL status, and see that search contributes to nearly half of the SALs generated.

Additionally, after the Sankey is created we can adjust the diagram including colors, the location of the nodes, and the flow direction to customize the visualization. For example, we could adjust colors and layout to highlight specific "At-Risk" pathways or "High-Velocity" channels, giving you a report-ready visual of your commercial health.

Using Data Effectively to Guide Your Strategy and Tactics

Data for its own sake has limited usefulness - but if structured and visualized well, it can be an invaluable tool to help guide your work. We’d encourage all marketers to experiment with different ways of visualizing data. Doing so will help you understand your data better, identify data gaps, will provide insight into what your marketing is doing, and make you more conversant in explaining the results.

At Fractorial we can design and run complex, data-driven campaigns for you, and also build the platforms and approaches to enhance your ability to be a data-driven marketing organization. Contact us if you're interested in learning more.

Read article
View all articles

Ready to Build a Smarter Marketing Engine?

Our work helps teams turn complex data into growth — driving qualified leads, higher engagement, and stronger campaign performance across every channel.

Contact us
Contact us
Contact us